TABLE 1.
Baseline Characteristics of 595 Adults With HIV Infection and Current or Past Alcohol Problems, Overall and by Alcohol Consumption Status
| Total Sample 595 | None 353 (59%) | Abstinent 61 (10%) | Heavy 180 (30%) | P | |
|---|---|---|---|---|---|
| Age [y], mean (SD) | 41 (7.4) | 41 (7.3) | 41 (8.2) | 41 (7.4) | 0.54 |
| Male, No. (%) | 446 (75) | 252 (71) | 53 (87) | 141 (78) | 0.02 |
| Race, No. (%) | |||||
| Black | 245 (41) | 141 (40) | 24 (39) | 80 (44) | |
| White | 202 (34) | 115 (33) | 21 (34) | 66 (37) | 0.30 |
| Other | 147 (25) | 97 (27) | 16 (26) | 34 (19) | |
| Homeless, No. (%) | 163 (27) | 92 (26) | 12 (20) | 59 (33) | 0.09 |
| CD4 count [cells/µL], median (IQR)* | 372 (209, 565.5) | 378.5 (209, 564) | 408.5 (268, 624) | 337 (184, 539) | 0.15 |
| CD4%, median (IQR)† | 22 (14, 30) | 22 (14, 30) | 25 (17, 32) | 21 (14, 30) | 0.42 |
| Log10 HIV RNA, mean (SD)‡ | 3.3 (1.2) | 3.2 (1.2) | 3.0 (1.2) | 3.5 (1.2) | 0.02 |
| HIV viral load [copies/mL], median (IQR)‡ | 1400 (0, 19,662) | 963 (0, 17,988) | 976 (0, 9554) | 3031 (94, 31,490) | 0.96 |
| HIV risk group, No. (%) | |||||
| Heterosexual/blood | 140 (24) | 76 (22) | 12 (20) | 52 (30) | |
| Injection drug use | 313 (54) | 207 (61) | 28 (46) | 78 (45) | 0.001 |
| MSM | 123 (21) | 59 (17) | 21 (34) | 43 (25) | |
| CES-D, mean (SD) | 22 (13) | 22 (13) | 20 (14) | 23 (13) | 0.28 |
| Current alcohol dependence, No. (%)§ | 29 (12) | 14 (9) | 0 (0) | 15 (22) | 0.005 |
| Lifetime alcohol dependence, No. (%)§ | 222 (91) | 135 (89) | 23 (96) | 64 (93) | 0.42 |
| Current drug dependence, No. (%)§ | 103 (42) | 65 (43) | 6 (25) | 32 (46) | 0.18 |
| Drinks per day, median (IQR) | 0 (0, 0.7) | 0 (0, 0) | 0.17 (0.07, 0.40) | 2.6 (0.8, 6.8) | <0.0001 |
| Drinks per day, mean (SD) | 2.2 (8.2) | 0 (0) | 0.4 (0.5) | 7.2 (13.7) | <0.0001 |
| Currently receiving ART, No. (%) | 355 (60) | 218 (62) | 37 (61) | 100 (56) | 0.38 |
| 100% adherent, past 3 days, No. (%) | 249 (70) | 170 (78) | 20 (54) | 59 (59) | 0.0002 |
| ART adherence status, No. (%) | |||||
| Not on medications | 239 (40) | 135 (38) | 24 (39) | 80 (44) | |
| On medications, not adherent | 105 (18) | 47 (13) | 17 (28) | 41 (23) | 0.0007 |
| On medications, adherent | 249 (42) | 170 (48) | 20 (33) | 59 (33) | |
| ART ever, No. (%)∥ | 467 (81) | 283 (83) | 47 (77) | 137 (79) | 0.39 |
| Study cohort, No. (%) | |||||
| HIV-LIVE only | 245 (41) | 152 (43) | 24 (39) | 69 (38) | |
| HIV-ALC only | 195 (33) | 125 (35) | 17 (28) | 53 (29) | |
| Both | 154 (26) | 76 (22) | 20 (33) | 58 (32) | 0.06 |
*
n = 572 (Total), n = 338 (Abstinent), n = 58 (Moderate), n = 175 (Heavy).
†
n = 568 (Total), n = 336 (Abstinent), n = 58 (Moderate), n = 173 (Heavy).
‡
n = 557 (Total), n = 330 (Abstinent), n = 55 (Moderate), n = 171 (Heavy).
§
n = 245 (Total), n = 152 (Abstinent), n = 24 (Moderate), n = 69 (Heavy).
∥
n = 577 (Total), n = 342 (Abstinent), n = 61 (Moderate), n = 174 (Heavy).